Evidence map›Paper›PMID 28639812›Full record

ReviewPsychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors2017

Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?

Nancy M Petry, Sheila M Alessi, Todd A Olmstead, Carla J Rash, Kristyn Zajac

Registry-linked trialOpen access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07465588 (Randomized Evaluation of Incentives FOR Clinical Effectiveness in Liver Recovery), which is not on this map. Cited by 81 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 6 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07465588 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Randomized Evaluation of Incentives FOR Clinical Effectiveness in Liver Recovery (REINFORCE Trial): A PEth-Based Contingency Management Pilot Randomized Controlled Trial for Alcohol Use Disorder in Patients With Alcohol-Associated Liver Disease

TypeinterventionalSponsorMassachusetts General HospitalRan2026 to 2028Enrolled90ConditionsAlcohol Use Disorder, Alcohol-associated Liver Disease, Liver Cirrhosis, Alcoholic, Alcohol-Associated HepatitisArmsPEth Based Contingency Management, PEth Monitoring with Fixed Incentives
3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 6 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Contingency management for treatment attendance: A meta-analysis.Journal of substance abuse treatment · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Contingency Management Versus Psychotherapy for Prenatal Smoking Cessation: A Meta-Analysis of Randomized Controlled Trials.Women's health issues : official publication of the Jacobs Institute of Women's Health
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Review
  19. Article
  20. Integrating HIV and Stimulant-Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nancy M PetryCalhoun Cardiology Center, University of Connecticut School of Medicine.
Sheila M AlessiCalhoun Cardiology Center, University of Connecticut School of Medicine.
Todd A OlmsteadDepartment of Public Affairs, University of Texas-Austin.
Carla J RashCalhoun Cardiology Center, University of Connecticut School of Medicine.
Kristyn ZajacCalhoun Cardiology Center, University of Connecticut School of Medicine.
University of Connecticut · US

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
Vulnerabilities for coping-related drinking among post-college young adultsP60AA003510 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI BAUER, LANCE O. · 2008 to 2017
$17.5M
WHO COLLABORATIVE PROJECT ON MANAGEMENT OF HARMFUL ALCOHOL CONSUMPTIONP50AA003510 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KRANZLER, HENRY RICHARD · 1985 to 2007
$13.6M
VOUCHERS VS PRIZES--CONTINGENCY MANAGEMENTR01DA013444 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE · 2000 to 2015
$6.2M
ART Adherence and Secondary Prevention of HIVR01HD075630 · NICHD · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RASH, CARLA J · 2012 to 2016
$3.3M
Interventions for Unemployed Hazardous DrinkersR01AA023502 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE, RASH, CARLA J · 2015 to 2019
$3.1M
Contingency Management for Alcohol Use DisordersR01AA021446 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE · 2013 to 2016
$2.6M
Treating Co-Occurring PTSD and Substance Abuse in High-Risk Transition Age YouthK23DA034879 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ZAJAC, KRISTYN · 2014 to 2018
$964k
IVR Technology to Mobilize Contingency Management for Smoking CessationR21DA029215 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE · 2011 to 2012
$416k
NIAAA NIH HHS P50 AA003510NIAAA NIH HHS P60 AA003510NIAAA NIH HHS R01 AA021446NIAAA NIH HHS R01 AA023502NICHD NIH HHS R01 HD075630NIDA NIH HHS K23 DA034879NIDA NIH HHS P50 DA009241NIDA NIH HHS R01 DA013444NIDA NIH HHS R21 DA029215NIH HHS
6 · The paper itself

Abstract

Contingency management (CM) interventions consistently improve substance abuse treatment outcomes, yet CM remains a highly controversial intervention and is rarely implemented in practice settings. This article briefly outlines the evidence base of CM and then describes 4 of the most often-cited concerns about it: philosophical, motivational, durability, and economic. Data supporting and refuting each of these issues are reviewed. The article concludes with suggestions to address these matters and other important areas for CM research and implementation, with the aims of improving uptake of this efficacious intervention in practice settings and outcomes of patients with substance use disorders. (PsycINFO Database Record

Indexed as

Behavior TherapyHumansMotivationSubstance-Related DisordersTreatment Outcome

Identifiers

PMID28639812
PMCPMC5714694
OpenAlexW2666006138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.